Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling

Journal of Cardiovascular Translational Research

Volumn 7, Issue 2, 2014, Pages 250-261

  Motiwala, Shweta R ^a   Szymonifka, Jackie ^a   Belcher, Arianna ^a   Weiner, Rory B ^a   Baggish, Aaron L ^a   Gaggin, Hanna K ^a   Bhardwaj, Anju ^a   Januzzi, James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biomarkers; Heart failure; Outcomes; Prognosis; Remodeling

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGLYCAN; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOSTATIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; LOOP DIURETIC AGENT; MEMBRANE PROTEIN; MIMECAN; MINERALOCORTICOID ANTAGONIST; SECRETED FRIZZLED RELATED PROTEIN 3; SOMATOMEDIN BINDING PROTEIN; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY DILATATION; ARTICLE; BODY MASS; CONTROLLED STUDY; CRACKLE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84896389559     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-013-9522-8     Document Type: Article

References (30)

1. Chen, A. A., Wood, M. J., Krauser, D. G., Baggish, A. L., Tung, R., Anwaruddin, S., Picard, M. H., & Januzzi, J. L. (2006). NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J, 27 (7), 839-845.
2. Januzzi, J. L., Jr., Sakhuja, R., O'Donoghue, M., Baggish, A. L., Anwaruddin, S., Chae, C. U., Cameron, R., Krauser, D. G., Tung, R., Camargo, C. A., Jr., & Lloyd-Jones, D. M. (2006). Utility of aminoterminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department. Arch Intern Med, 166 (3), 315-320. (Pubitemid 43244319)
3. Januzzi, J. L., Jr., Rehman, S., Mohammed, A. A., Bhardwaj, A., Barajas, L., Barajas, J., Kim, H.-N., Baggish, A. L., Weiner, R. B., Chen, A. A., Marshall, J. E.,Moore, S. A., Carlson,W. D., Lewis, G. D., Shin, J., Sullivan, D., Parks, K., Wang, T. J., Gregory, S., Uthamalingam, S., & Semigran, M. J. (2011). Use of aminoterminal Pro-B type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol, 58, 1881-1889.
4. Baggish, A. L., van Kimmenade, R. R., & Januzzi, J. L., Jr. (2008). The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol, 101 (3A), 43-48.
5. Mann, D. L., Barger, P. M., & Burkhoff, D. (2012). Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol, 60 (24), 2465-2472.
6. Weiner, R. B., Baggish, A. L., Chen-Tournoux, A., Marshall, J. E., Gaggin, H. K., Bhardwaj, A., Mohammed, A. A., Rehman, S. U., Barajas, L., Barajas, J., Gregory, S. A.,Moore, S.A., Semigran,M. J., & Januzzi, J. L., Jr. (2013). Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights fromthe ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study. European journal of heart failure, 15 (3), 342-351.
7. Chugh, S., Ouzounian, M., Lu, Z., Mohamed, S., Li, W., Bousette, N., Liu, P. P., & Gramolini, A. O. (2013). Pilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failure. Proteomics, 13 (15), 2324-2334.
8. Bhardwaj, A., Rehman, S. U., Mohammed, A., Baggish, A. L., Moore, S. A., & Januzzi, J. L., Jr. (2010). Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored ChronicHeart Failure Therapy (PROTECT) study. American heart journal, 159 (4), 532-538. e531.
9. Ahmed, M. S., Oie, E., Vinge, L. E., Yndestad, A., Andersen, G. G., Andersson, Y., Attramadal, T., & Attramadal, H. (2003). Induction of myocardial biglycan in heart failure in rats - an extracellular matrix component targeted by AT(1) receptor antagonism. Cardiovascular research, 60 (3), 557-568. (Pubitemid 37501113)
10. Askevold, E. T., Aukrust, P., Nymo, S., Aakhus, S., Ranheim, T., Fiane, A., Dahl, C. P., Finsen, A. V., Yndestad, A., Gullestad, L., Latini, R., Masson, S., Tavazzi, L., & Ueland, T. (2012). GISSI-HF Investigators. Abstract 18191: secreted frizzled related protein 3, an inhibitor of Wnt-signaling, is upregulated in clinical and experimental heart failure. Circulation, 126 (21 Supplement), A18191.
11. Isobe, K., Kuba, K.,Maejima, Y., Suzuki, J., Kubota, S., & Isobe, M. (2010). Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model. Circulation journal : official journal of the Japanese Circulation Society, 74 (1), 109-119.
12. Gramolini, A. O., Kislinger, T., Alikhani-Koopaei, R., Fong, V., Thompson, N. J., Isserlin, R., Sharma, P., Oudit, G. Y., Trivieri, M. G., Fagan, A., Kannan, A., Higgins, D. G., Huedig, H., Hess, G., Arab, S., Seidman, J. G., Seidman, C. E., Frey, B., Perry, M., Backx, P. H., Liu, P. P., MacLennan, D. H., & Emili, A. (2008). Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Molecular & cellular proteomics : MCP, 7 (3), 519-533. (Pubitemid 351472462)
13. Dinh,W, Coll Barroso,M, Futh, R, Lankisch, M, Klein, R, Gulker, J, Bufe, A, Scheffold, T, Nickl,N, Seyfarth, M. 92012) Abstract P1288: Serum insulin like growth factor-i and its binding protein-7: novel promising biomarker in heart failure with preserved ejection fraction. Clinical Research in Cardiology ; 101(Supplement 1).
14. Petretto, E., Sarwar, R., Grieve, I., Lu, H., Kumaran,M. K.,Muckett, P. J., Mangion, J., Schroen, B., Benson, M., Punjabi, P. P., Prasad, S. K., Pennell, D. J., Kiesewetter, C., Tasheva, E. S., Corpuz, L. M., Webb, M. D., Conrad, G. W., Kurtz, T. W., Kren, V., Fischer, J., Hubner, N., Pinto, Y. M., Pravenec, M., Aitman, T. J., & Cook, S. A. (2008). Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet, 40 (5), 546-552. (Pubitemid 351601220)
15. Voss, S, Nef, H, Szardien, S, Troidl, C, Kojonazarov, B, Visser, D, Hoffmann, J, Willmer, M, Hamm, C. W, Moellmann, H. 92012) Abstract 2014: Osteoglycin deficiency leads to maladaptive remodeling and severe cardiac dysfunction in a mouse model of cardiac hypertrophy. Eur Heart J; 33(Supplement 1):342.
16. Lang, R.M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J., Solomon, S., & Spencer, K. T. (2006). St John Sutton M. StewartW. Recommendations for chamber quantification. Eur J Echocardiogr, 7 (2), 79-108. (Pubitemid 43257193)
17. Brandan, E., Cabello-Verrugio, C., & Vial, C. (2008). Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol, 27 (8), 700-708.
18. Fadic, R., Mezzano, V., Alvarez, K., Cabrera, D., Holmgren, J., & Brandan, E. (2006). Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med, 10 (3), 758-769. (Pubitemid 44874284)
19. Hoang, B., Moos, M., Jr., Vukicevic, S., & Luyten, F. P. (1996). Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem, 271 (42), 26131-26137. (Pubitemid 26347456)
20. Svensson, A., Norrby, M., Libelius, R., & Tagerud, S. (2008). Secreted frizzled related protein 1 (Sfrp1) and Wnt signaling in innervated and denervated skeletal muscle. J Mol Histol, 39 (3), 329-337.
21. Tufan, A. C., Daumer, K. M., & Tuan, R. S. (2002). Frizzled-7 and limb mesenchymal chondrogenesis: effect of misexpression and involvement of N-cadherin. Dev Dyn, 223 (2), 241-253. (Pubitemid 34113402)
22. Glenjen, N., Mosevoll, K.A., & Bruserud, O. (2002). Serumlevels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia. Int J Cancer, 101 (1), 86-94. (Pubitemid 34833002)
23. Miyashita, M., Tajiri, T., Yanagi, K., Shimizu, T., Futami, R., Sasajima, K., & Tokunaga, A. (2003). Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors. Hepatogastroenterology, 50 (50), 308-309. (Pubitemid 36390506)
24. Gu, X. S., Lei, J. P., Shi, J. B., Lian, W. L., Yang, X., Zheng, X., & Qin, Y. W. (2011). Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats. Mol CellBiochem, 352 (1-2), 309-316.
25. Jazbutyte, V., Fiedler, J., Kneitz, S., Galuppo, P., Just, A., Holzmann, A., Bauersachs, J., & Thum, T. (2012). MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age (Dordr), 35 (3), 747-762.
26. Cavallari, L. H., & Limdi, N. A. (2009). Warfarin pharmacogenomics. Curr Opin Mol Ther, 11 (3), 243-251.
27. Grzymala-Lubanski, B., Sjalander, S., Renlund, H., Svensson, P. J., & Sjalander, A. (2013). Computer aided warfarin dosing in the Swedish national quality registry AuriculA - algorithmic suggestions are performing better than manually changed doses. Thromb Res, 131 (2), 130-134.
28. Motiwala, S. R., Szymonifka, J., Belcher, A., Weiner, R. B., Baggish, A. L., Sluss, P., Gaggin, H. K., Bhardwaj, A., & Januzzi, J. L. (2013). Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail, 15 (10), 1157-1163.
29. van Kimmenade, R. R., & Januzzi, J. L., Jr. (2012). Emerging biomarkers in heart failure. Clin Chem, 58 (1), 127-138.
30. Januzzi, J. L., Jr. (2013). Natriuretic peptides as biomarkers in heart failure. J Investig Med, 61 (6), 950-955.